SGLT2 Inhibitors for Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Time to Deliver Implementation

By sjmartinez • September 13, 2022

Greene SJ, Fonarow GC, Butler J. SGLT2 Inhibitors for Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Time to Deliver Implementation. Eur J Heart Fail. 2022 Sep 13. doi: 10.1002/ejhf.2688. Epub ahead of print. PMID: 36097872.

Tags: Cardiology/Epi, Publications

Bioelectronic block of stellate ganglia mitigates pacing-induced heterogeneous release of catecholamine and neuropeptide Y in the infarcted pig heart

Vrabec T, Bender S, Chan SA, Cha S, Haridas S, Hanna P, Ajijola OA, Shivkumar K, Smith C, Ardell JL. Bioelectronic block of stellate ganglia[...]

Atrial Arrhythmias After PFO Device Closure: Common, Clinically Important, and Preventable

Tobis JM, Carroll JD. Atrial Arrhythmias After PFO Device Closure: Common, Clinically Important, and Preventable? Circulation. 2024 Nov 19;150(21):1669-1670. doi: 10.1161/CIRCULATIONAHA.124.071851. Epub 2024 Nov 18.[...]

Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

Abdel Jawad M, Spertus JA, Ikeaba U, Greene SJ, Fonarow GC, Chiswell K, Chan PS. Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With[...]